Quantcast

Latest Derma Sciences Inc. Stories

2014-08-03 16:20:59

DALLAS, August 3, 2014 /PRNewswire/ -- Wound Care Market by Type (Traditional (Wound Closure, Anti infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, Alginate, Collagen), Active (Artificial Skin & Skin Substitutes), Pressure Relief Devices, NPWT) - Global Forecast to 2019 is an August 2014 industry research report spread across 320 pages. Profiling companies like 3M Company, Baxter International, Inc., Coloplast A/S, Convatec Healthcare B S.A.R.L,...

2013-04-22 23:04:03

Derma Sciences, Inc. is pleased to announce that Ed Quilty, President & CEO of Derma Sciences, Inc. (NASDAQ: DSCI) will be presenting at the Taglich Brothers 10th Annual Small Cap Equity Conference May 7, 2013. New York, NY (PRWEB) April 22, 2013 Derma Sciences, Inc. is pleased to announce that Ed Quilty, President & CEO of Derma Sciences, Inc. (NASDAQ: DSCI) will be presenting at the Taglich Brothers 10th Annual Small Cap Equity Conference May 7, 2013. The Conference will take...

2010-07-14 16:34:00

NEW YORK, July 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI) announces the following Webcast: What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 11:30 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=160488 Live over the Internet --Simply log on to the web at How: the address above. Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com If you are unable to...

2010-06-09 07:17:00

PRINCETON, N.J., June 9 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, has been awarded the Healthcare Common Procedural Coding System (HCPCS) code A6266 for its BIOGUARD(TM) Conforming Bandage. This code, which was awarded by the Centers for Medicare and Medicaid Services (CMS), is the same as that assigned for other antimicrobial large roll gauze dressings, and allows the Conforming Bandage to be...

2010-06-07 06:45:00

PRINCETON, N.J., June 7 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that its ALGICELL® Ag wound dressings have received a CE mark for use in the European Union. SGS Group, the world's largest Control and Inspection Company, supervised the assessment and certification process. The CE marking verifies that ALGICELL® Ag has met all relevant...

2010-06-03 13:33:00

PRINCETON, N.J., June 3 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J. Quilty, Chairman and CEO, will make a presentation regarding the business strategy and financial outlook of the Company at the Noble Financial Sixth Annual Equity Conference at 12:30pm EDT on June 8, 2010, at the Hard Rock Hotel in Hollywood, Florida. The presentation will be webcast LIVE featuring...

2010-05-13 08:00:00

PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months ended March 31, 2010. Highlights for First Quarter 2010: Net sales increased 23% to $12,844,382 versus $10,431,891 in first quarter 2009. Advanced wound care sales increased 70% to $2,281,564 versus $1,346,223 in first quarter 2009. Net loss was...

2010-05-12 06:49:00

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that it has established an international subsidiary, Derma Sciences Europe Limited, and will soon be opening an office near London, England. "Europe represents a substantial growth opportunity for Derma Sciences and is a logical next step in expanding our sales efforts," said Edward J. Quilty, Derma Sciences'...

2010-05-11 11:56:00

PRINCETON, N.J., May 11 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, will present at the Rodman & Renshaw Annual Global Investment Conference. The Conference will take place May 16 - 18, 2010 at the Grosvenor House Hotel in London, UK. Edward J. Quilty, Chairman and CEO of Derma Sciences will present on Tuesday, May 18, 2010 at 10:40 am BST (5:40 am ET) in the Spencer Suite. Additional...

2010-05-04 06:49:00

PRINCETON, N.J., May 4 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the launch of its new XTRASORB(TM) Foam dressing. The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010. The majority of chronic wounds tend to have moderate to heavy levels of wound fluid, which is best managed...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related